XML 135 R78.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Restructuring costs and similar items (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Analysis of income and expense [abstract] |
Summary of Restructuring Costs and Similar Items | Restructuring costs and similar items amounted to €1,396 million in 2024, €1,030 million in 2023 and €1,077 million in 2022, and were comprised of the following items:
(€ million) | 2024 | 2023 | (a) | 2022 | (a)
Employee-related expenses | 963 | 404 |  | 471 |
Charges, gains or losses on assets(b) | 4 | 273 |  | 261 |
Costs related to transformation programs | 285 | 330 |  | 325 |
Other | 144 | 23 |  | 20 |
Total | 1,396 | 1,030 |  | 1,077 |
(a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation. (b)This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sano fi.

X
- References No definition available. + Details
Name: | ifrs-full_AnalysisOfIncomeAndExpenseAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of restructuring costs details. + References No definition available. + Details
Name: | sny_DisclosureOfRestructuringCostsDetailsTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration